Robert Molpus
Psychiatry · Longwood, FLNPI 1255306734
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $870 of the $1,183 with a category attached, or 73.6%. Every reported general payment came from a single manufacturer, Boehringer Ingelheim.
Across 9 payments — averaging $131.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$1K
Across 1,730 payments — averaging $3208.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Axsome Therapeutics, Inc.$875K
- AbbVie$835K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$716K
- Indivior Inc.$568K
- Takeda Pharmaceuticals U.S.A., Inc.$490K
- Teva Pharmaceuticals USA, Inc.$402K
- plus $1.7M from 21 others
What the payments were for
- Travel & lodging$87074%
- Food & beverage$31226%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 9 | $1,183 |
How this compares
$1,183 in reported general payments places this provider in the 65th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Longwood
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
- David SheehanTampa$631K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.